By Predicting What You Like, Hooked Makes Ads For Mobile Games Less Terrible

With Wakelet, you can curate topics, gather event highlights, and assemble a portfolio of your work. This article is republished with permission from Wonder Tools, a newsletter that helps you discover the most useful sites and apps. Subscribe here.

Limelight Steel wants to make steel production less carbon intensive—so it’s turning to an unlikely source. Steel is the most widely used metal in the world. You’ll find it in everything from cars to cutlery to skyscrapers. It’s truly a building block for modern society.

IRA investments are helping clean energy drive ‘a new era in American manufacturing.’ This article originally appeared on Inside Climate News. It is republished with permission.

Pig-to-human organ transplants have shown minimal success. We ought to be investing in better, less cruel alternatives. Earlier this week, it was reported that Rick Slayman, the first person to ever receive a transplanted pig kidney, sadly passed away less than two months after the procedure. While the hospital, Massachusetts General, has stated that there’s no evidence that the patient’s death was a direct result of the transplant, it’s clear that the surgery did not succeed in substantially extending Slayman’s life.

Small businesses are currently exempt from the SEC’s climate disclosure rules—but that doesn’t mean they should ignore them. Over the past several years, many large U. S. companies have taken cues from their international counterparts and prioritized environmental, social, and governance (ESG) initiatives. Companies looking to establish transparency, trust, and accountability in human capital and sustainability reporting may have started out voluntarily—but that may not be the case much longer.

AstraZeneca Plc plans to build a $1.5 billion manufacturing facility in Singapore to make antibody-drug conjugates as the U. K. drugmaker pushes to beef up its ability to produce the next-generation cancer treatments. The plant will be Astra’s first drug-conjugate facility to produce the medicines from start to finish, the company said in a statement Monday.